These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21822457)

  • 1. N-(4-Hydroxyphenyl) Retinamide Potentiated Anti-tumor Efficacy of Genistein in Human Ewing's Sarcoma Xenografts.
    Karmakar S; Choudhury SR; Banik NL; Ray SK
    World J Oncol; 2011 Apr; 2(2):53-63. PubMed ID: 21822457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of N-(4-hydroxyphenyl) retinamide and genistein increased apoptosis in neuroblastoma SK-N-BE2 and SH-SY5Y xenografts.
    Karmakar S; Choudhury SR; Banik NL; Ray SK
    Neuroscience; 2009 Sep; 163(1):286-95. PubMed ID: 19540315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Mitochondrial Pathways and Endoplasmic Reticulum Stress for Increasing Apoptosis in Ectopic and Orthotopic Neuroblastoma Xenografts.
    Karmakar S; Choudhury SR; Banik NL; Ray SK
    J Cancer Ther; 2011 Jun; 2(2):77-90. PubMed ID: 22468231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EWS Knockdown and Taxifolin Treatment Induced Differentiation and Removed DNA Methylation from p53 Promoter to Promote Expression of Puma and Noxa for Apoptosis in Ewing's Sarcoma.
    Hossain MM; Ray SK
    J Cancer Ther; 2014 Oct; 5(12):1092-1113. PubMed ID: 27547487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 inhibitor HA14-1 and genistein together adeptly down regulated survival factors and activated cysteine proteases for apoptosis in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells.
    Mohan N; Karmakar S; Choudhury SR; Banik NL; Ray SK
    Brain Res; 2009 Aug; 1283():155-66. PubMed ID: 19505441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice.
    Karmakar S; Banik NL; Ray SK
    Cancer; 2008 Feb; 112(3):596-607. PubMed ID: 18098270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-185 suppresses progression of Ewing's sarcoma via inhibiting the PI3K/AKT and Wnt/β-catenin pathways.
    Zhang S; Li D; Jiao GJ; Wang HL; Yan TB
    Onco Targets Ther; 2018; 11():7967-7977. PubMed ID: 30519038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
    Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
    J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity.
    Merchant MS; Woo CW; Mackall CL; Thiele CJ
    J Natl Cancer Inst; 2002 Nov; 94(22):1673-9. PubMed ID: 12441322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
    Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
    Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-(4-Hydroxyphenyl) retinamide induced both differentiation and apoptosis in human glioblastoma T98G and U87MG cells.
    Das A; Banik NL; Ray SK
    Brain Res; 2008 Aug; 1227():207-15. PubMed ID: 18602901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma.
    Werner S; Mendoza A; Hilger RA; Erlacher M; Reichardt W; Lissat A; Konanz C; Uhl M; Niemeyer CM; Khanna C; Kontny U
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):19-31. PubMed ID: 17823799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoids induce differentiation and downregulate telomerase activity and N-Myc to increase sensitivity to flavonoids for apoptosis in human malignant neuroblastoma SH-SY5Y cells.
    Das A; Banik NL; Ray SK
    Int J Oncol; 2009 Mar; 34(3):757-65. PubMed ID: 19212680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
    Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
    Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon gamma enhances the effectiveness of tumor necrosis factor-related apoptosis-inducing ligand receptor agonists in a xenograft model of Ewing's sarcoma.
    Merchant MS; Yang X; Melchionda F; Romero M; Klein R; Thiele CJ; Tsokos M; Kontny HU; Mackall CL
    Cancer Res; 2004 Nov; 64(22):8349-56. PubMed ID: 15548704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
    Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
    Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ganitumab (AMG 479), alone and in combination with rapamycin, in Ewing's and osteogenic sarcoma models.
    Beltran PJ; Chung YA; Moody G; Mitchell P; Cajulis E; Vonderfecht S; Kendall R; Radinsky R; Calzone FJ
    J Pharmacol Exp Ther; 2011 Jun; 337(3):644-54. PubMed ID: 21385891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
    Batra S; Reynolds CP; Maurer BJ
    Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of all-trans retinoic acid and taxol regressed glioblastoma T98G xenografts in nude mice.
    Karmakar S; Banik NL; Patel SJ; Ray SK
    Apoptosis; 2007 Nov; 12(11):2077-87. PubMed ID: 17701358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma.
    Lau YS; Adamopoulos IE; Sabokbar A; Giele H; Gibbons CL; Athanasou NA
    Br J Cancer; 2007 Jun; 96(11):1716-22. PubMed ID: 17533390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.